Technetium-99m sestamibi retention in skeletal muscles, a potential indicator of mitochondrial function and anaerobic threshold in patients with type 2 diabetes
In this study, we investigated the retention of technetium-99m sestamibi (MIBI), a radiopharmaceutical that accumulates in mitochondria, in patients with type 2 diabetes.We hypothesized that patients with Cutting Board Mats type 2 diabetes had lower MIBI counts in their legs than non-diabetic volunteers, and that these abnormalities reflected a low